InnoCare Pharma is a leading biopharmaceutical company based in China, dedicated to discovering, developing, and commercializing best-in-class and first-in-class drugs for the treatment of cancer and autoimmune diseases. With a world-class management team of seasoned industry executives, InnoCare has built a fully integrated biopharmaceutical platform that encompasses every aspect of the drug development cycle. Their strong in-house R&D capabilities include drug target identification and verification, preclinical evaluation, clinical trial design and execution, drug manufacturing, quality control, and commercialization.

Leveraging the team's global vision and local expertise, InnoCare has developed a balanced drug portfolio targeting both proven and novel biological pathways. InnoCare strategically focuses on therapies for the treatment of cancer and autoimmune diseases, two areas with significant market opportunity and synergies. Their vision is to become a global biopharmaceutical leader that develops and delivers innovative therapies for patients worldwide.

By overseeing all aspects of the drug development cycle in-house, InnoCare ensures operational efficiency and maintains control of quality at every step. They are committed to providing the best products to the market and improving the lives of patients battling cancer and autoimmune diseases